TIM-3 is the most expressed immune checkpoint receptor on tumor NK cells in HCC, and inhibition of TIM-3 enhances the antitumor effect of PD-1 blockers (36). The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.